Termination of Agreement with

RNS Number : 6864Y

Tristel PLC

30 December 2010

 



Tristel plc

("Tristel" or "the Company")

AIM: TSTL

Tristel plc ("Tristel") announces that the Development and Licence agreement with The Clorox Company ("Clorox"), Oakland, United States, has been terminated.  The agreement was entered into in September 2009 and licensed Tristel's technology to Clorox for use in the hospital surfaces disinfection market.

Tristel had not assumed that any royalty income would be earned under the agreement until financial year 2015-16 at the earliest.  The termination will have no financial impact on Tristel's current year or next year results.

Commenting upon the termination, Paul Swinney, CEO Tristel, said:

"Whilst we're disappointed with the termination of the agreement, during the period of co-operation we learnt a huge amount about the United States market and its regulatory processes.  Clorox's commercial interest in our technology was only for environmental surfaces, which is only part of Tristel's involvement in the hospital marketplace, and we will now look at the wider opportunities in North America". 

For further information, please contact:

Tristel plc
Paul Swinney, Chief Executive	Tel: [phone]
finnCap
Geoff Nash / Charlotte Stranner (Corporate Finance)	Tel: [phone]
Simon Starr (Corporate Broking)
Walbrook PR	Tel: [phone]
Helen Westaway	[e-mail]
Fiona Henson	[e-mail]

 

END

 

 

MSCZMMZZNLDGGZM